Publications by authors named "T Szydelko"

: Robot-assisted radical prostatectomy (RARP) for the treatment of prostate cancer (PCa) has been standardized over the last 20 years. At our institution, only n = 3 rob arms are used for RARP. In addition, n = 2, 12 mm lap trocars are placed for the bedside assistant symmetrically at the midclavicular lines, which allows for direct pelvic triangulation and greater involvement of the assisting surgeon.

View Article and Find Full Text PDF

Purpose: The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of the percutaneous cryoablation (PCA) procedure developed based on one year of experience with 81 PCA procedures.

Material And Methods: The percutaneous cryoablation programme at Wroclaw Medical University Hospital has been successfully operating for a year.

View Article and Find Full Text PDF

Implantation of inflatable penile prosthesis should be considered as a definitive treatment of erectile dysfunction. However, the sole procedure might not allow for optimal dimensional and functional outcomes. The aim of this study was to systematically review the literature and present the findings on the optimal choice of perioperative methods, surgical techniques, and pharmacotherapy to improve penile length, curvature, and erectile function.

View Article and Find Full Text PDF

Background: Penile cancer is a relatively rare neoplasm in developed countries, with the majority of newly diagnosed cases presenting as organ-confined, with a 5-year survival rate of 90%. Therefore, it is crucial to consider the impact of penile tumor resection on sexual and urinary function. Regrettably, the literature is devoid of comprehensive, step-by-step video instructions for the surgical procedure of partial penectomy with reconstruction using a split-thickness skin graft (0.

View Article and Find Full Text PDF
Article Synopsis
  • Avelumab is an antibody that targets PD-L1 in cancer cells, focusing on its effects on two potential cancer targets, CD15 and IL-17RA, which are influenced by the STAT3 protein.
  • The study aimed to see if treating renal cancer cells with avelumab affects CD15 and IL-17RA expression and how STAT3 mediates this regulation.
  • Results showed that avelumab treatment reduced STAT3 levels, increased CD15 expression in certain cancer cells, and altered IL-17RA levels only in healthy cells, highlighting the complex role these proteins play in cancer therapy.
View Article and Find Full Text PDF